PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Tulobuterol HCl, 98% (HPLC)
CAS No 65629-1g
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 234,000¿ø
Æ÷Àå´ÜÀ§



2-tert-Butylamino-1-(2-chlorophenyl)ethanol hydrochloride



 

¡Ø È­Çиí : Tulobuterol HCl, 98% (HPLC)

 

¡Ø µî±Þ : APIs and Bioactives > Adrenergic Agonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 1g , 5g

 

¡Ø È­ÇÐ½Ä : C12H19Cl2NO

 

¡Ø CAS # : [56776-01-3]

 

 

IDENTITY
CAS Registry #:

 

[56776-01-3]

MDL Number: MFCD00214398
MF: C12H19Cl2NO
MW: 264.19
SPECIFICATIONS & PROPERTIES
Purity: 98% (HPLC)
Available Spectra: LCMS, HPLC
Physical Form: White crystalline powder or powder
Melting Point: 159-164¡ÆC
Long-Term Storage:

 

Store long-term at 2-8¡ÆC

Shipping: Not Regulated for Shipping

BIOLOGICAL INFO
Form: HCl salt

REVIEW

Tulobuterol is a long-acting beta2-adrenergic receptor agonist,which acts as a bronchodilator, marketed in Japan as a transdermal patch under the name Hokunalin tape. This is the first bronchodilator to be available as a transdermal patch, and isused in the treatment of chronic obstructive lung disease.

REFERENCES
[1] Kubo, S.; Kase, Y.; Miyata, T.; Kito, G.; Uesaka, I. Pharmacological studies of 1-(o-chlorophenyl)-2-tert-butylaminoethanol (C-78), a new bronchodilator. Arzneimittel-Forschung (1975), 25(7), 1028-37.
[2] Bogan, J. A. Tulobuterol hydrochloride. Drugs of Today (1982), 18(5), 238-43.
[3] Patel KR. Tulobuterol in the management of obstructive airways disease in adults. Clin Ther. 1985;7(4):452-67.
[4] Kato H, Nagata O, Yamazaki M, Suzuki T, Nakano Y. Yakugaku Zasshi. Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma. 2002 Jan;122(1):57-69.

Risk Description(s)
R22: Harmful if swallowed.

Safety Description(s)
S24/25: Avoid contact with skin and eyes.
S36: Wear suitable protective clothing.
S60: This material and its container must be disposed of as hazardous waste.